ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 3593

$348K Total Retail Price of All Prescriptions

Rank: 1161 out of 3593

650 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 650 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 650 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$25 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 818 788 1 3
LEVOXYL 778 719 2 111
OMEPRAZOLE 745 653 3 5
LISINOPRIL 697 649 4 2
SIMVASTATIN 687 648 5 1
ATORVASTATIN CALCIUM 523 476 6 15
METOPROLOL TARTRATE 503 465 7 8
WARFARIN SODIUM 476 445 8 18
LOSARTAN POTASSIUM 455 440 9 14
PRAVASTATIN SODIUM 337 309 10 13
HYDROCODONE-ACETAMINOPHEN 320 244 S3 11 7
TRIAMTERENE-HCTZ 311 297 12 66
METFORMIN HCL 309 285 13 6
ATENOLOL 308 264 14 11
GLIMEPIRIDE 294 274 15 44
SERTRALINE HCL 293 268 16 28
ENALAPRIL MALEATE 264 239 17 38
FUROSEMIDE 198 177 18 9
HYDROCHLOROTHIAZIDE 194 188 19 10
LOVASTATIN 172 165 20 20
ALENDRONATE SODIUM 151 145 21 22
K-TAB 142 130 22 217
METFORMIN HCL ER 134 128 23 67
RANITIDINE HCL 127 120 24 27
GLYBURIDE 125 125 R 25 55
ALLOPURINOL 122 110 26 35
FLUOXETINE HCL 119 104 27 60
TAMSULOSIN HCL 112 110 28 33
VENTOLIN HFA 110 92 29 80
GEMFIBROZIL 107 85 30 88
DILTIAZEM 24HR CD 105 92 31 173
ZOLPIDEM TARTRATE 104 92 32 12
CLONIDINE HCL 104 90 32 41
TRAMADOL HCL 98 86 34 17
CRESTOR 94 94 35 21
GABAPENTIN 88 88 36 16
LANOXIN 84 73 37 223
PANTOPRAZOLE SODIUM 80 69 38 45
PAROXETINE HCL 76 67 39 62
VERAPAMIL ER 68 68 40 99
FLUTICASONE PROPIONATE 67 36 41 32
PREDNISONE 67 67 41 49
DILTIAZEM HCL 67 67 41 250
CARVEDILOL 67 62 41 23
TERAZOSIN HCL 66 66 45 115
BENAZEPRIL HCL 63 59 46 69
CLOPIDOGREL 63 63 46 30
ZETIA 60 60 48 110
TRIAMTERENE-HYDROCHLOROTHIAZID 59 56 49 231
NIFEDIPINE ER 56 49 50 75
AZITHROMYCIN 52 46 51 34
LEVOTHYROXINE SODIUM 52 49 51 4
KLOR-CON 8 51 51 53 244
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.